Investment Stage

Focus Areas

About Investor

Philipp Sander is an Investment Analyst with IndieBio/SOSV in San Francisco, focusing on pre-seed investments for human and planetary health, with particular attention to Pharmaceuticals, Food and Beverage, EnergyTech, Chemicals, ClimateTech/CleanTech, BioTech, Diagnostics, DeepTech, Medical Devices, and Therapeutics, and investment ranges between $275K and $2.0M. His career includes experience as a Graduate Student Researcher at The Scripps Research Institute and various scientific and editorial roles at the University of Freiburg, reflecting his strong foundation in biochemistry and molecular biomedicine. Philipp holds a Master’s degree in Biochemistry & Biophysics from the University of Freiburg and a Bachelor’s degree in Molecular Biomedicine from the University of Bonn, complemented by international study at The University of Hong Kong. His scientific background and research experience provide him with unique insights into evaluating and supporting breakthrough biotech and climate tech startups.